Safety Concerns Mount Over Neurocrine’s Vykat XR as Eli Lilly Targets Black-Market Sales of Experimental Obesity Drug
The pharmaceutical landscape is currently grappling with a dual crisis involving high-stakes metabolic treatments, as...
The pharmaceutical landscape is currently grappling with a dual crisis involving high-stakes metabolic treatments, as...
For a patient receiving a cancer diagnosis, the world undergoes a sudden and violent contraction....
In a sharp and rare rebuke of a member state’s domestic health policy, senior officials...
The Trump administration on Wednesday formally introduced a comprehensive new framework designed to address the...
In a decision that fundamentally reshapes the financial landscape of the American healthcare system, the...
The 2025 data, released in mid-2026, reveals that the percentage of young adults who reported...
Negotiations are currently intensifying between the government of the Democratic Republic of the Congo (DRC)...
The controversy centers on an executive order signed by President Trump on Monday, which outlines...
The current landscape of health-focused AI is characterized by a massive influx of venture capital,...
The intersection of medical innovation and clinical implementation has long been defined by a paradoxical...